---
type: validation
scope: whole plan (Stage 17 of Business_Plan_Generation_Pipeline.md)
pipeline_stage: 17 (whole-plan citation audit)
run_date: 2026-07-25
auditor: 7 independent evidence-citation-agent threads (Sections 1-2, 3-4, 5-6, 7-8, 9-10, 11-12, 13-14), synthesized by the top-level session
status: "PASS — 9/9 fixes independently re-verified 2026-07-25, post-merge draft state; zero open citation failures"
---

# Stage 17 — Whole-Plan Citation Audit

## Independent re-verification — post-merge draft state (2026-07-25)

**Why this pass:** the summary below explicitly left the audit at "fixes applied, re-verification
pending," per the citation-audit skill's 0%-tolerance rule that Stage 18/19 cannot proceed until a fresh
independent pass confirms every fix holds. The drafts have also since been through a merge reconciliation
of two parallel verification lineages (union-of-corrections, Sections 02–07), so this pass verifies
against the drafts as they now stand, not the state at the original audit.

**Method:** for each of the 9 recorded hard failures, located the claim in the current draft and traced
its citation independently — confirming the cited note/row exists and actually supports the claim, not
taking the fix record's word for it. Then swept the whole plan for the two root-cause defect classes
(the `Topics/EBITDA.md` mis-citation; unlabeled single-point EBITDA framing) to catch any reintroduction
by the merge.

| # | Failure (original) | Verification result |
|---|---|---|
| 1 | S1: GMV figure mis-attributed to Section 2 §2.1 | **Holds.** Traceability table: "GMV of USD 9.5 billion, FY2025 \| `Problem_Charter.md`" — correct target, confirmed present. |
| 2 | S1: "6.0% Q4 2025" comparator mis-attributed | **Holds.** Traceability table: "Q4 2025 Adjusted EBITDA margin 6.0% (comparator) \| `Section_09_Financial_Plan.md` §9.3-9.4; `Section_03_Market_Analysis.md` §3.3" — matches the fix record exactly. |
| 3 | S1/S14: stale churn-scope claim ("Group or any country level") vs. S13's "Group or Egypt specifically" | **Holds.** S1 body: "...at Group level or for Egypt specifically — the only country the corpus addresses this question for at all." S13's own text: "...for talabat overall (Group)..." S14 traceability row 13: "...at Group level or for Egypt specifically..." All three agree. |
| 4 | S3: AI/personalisation EBITDA cited to `Topics/EBITDA.md` | **Holds (deeper tier).** Now cites `Facts/AI_Facts.md` (TLB-001 p.23; TLB-002 p.16) plus `Value_Driver_Tree_v2.md` N-09 — the merge note explains this satisfies the Stage 17 fix "at a deeper evidence tier" than the originally-planned `Topics/AI.md` re-point. `Topics/EBITDA.md` is cited nowhere for this claim. |
| 5 | S3: pro GMV-share mis-cited to Topics notes | **Holds.** Now cites `Facts/Talabat_Pro.md` (TLB-020 p.8; TLB-014 p.14) plus `Value_Driver_Tree_v2.md` N-08, both in prose (§3.2) and the traceability table. |
| 6 | S4: pro 32%→49% claim uncited | **Holds.** Prose and traceability table both carry "TLB-020, page 8; TLB-014, page 14; `Value_Driver_Tree_v2.md` N-08." |
| 7 | S4: FY2026 EBITDA margin stated as uncited single point | **Holds.** Now reads "the disclosed guided range of 4.4-4.8% of GMV, with ~4.6% as the guided mid-range" — a range, not a point, cited to TLB-020/TLB-014/Section 9 §9.3. |
| 8 | S8: false "established in Section 5.4" cross-reference for the 235TB/day figure | **Holds.** The phrase "established in Section 5" does not occur anywhere in Section 8; the figure stands independently cited to TLB-002 page 15. |
| 9 | S14: 3 occurrences of the `Topics/EBITDA.md` mis-citation for the AI/personalisation figure | **Holds.** Traceability row 4 now cites `Topics/AI.md` and `Value_Driver_Tree_v2.md` N-09; zero occurrences of `Topics/EBITDA.md` remain anywhere in Section 14. |

**Plan-wide root-cause sweep:** grepped all 14 drafts for every remaining `Topics/EBITDA.md` occurrence.
Three live citations remain (Section 2's EBITDA-bridge row — repointed to `Topics/2026 Investment
Programme.md`, this string is a fix-log entry describing that repointing, not a live cite; Section 4 §4.2
— cites `Topics/EBITDA.md` for the *realized 4.8% Q1 2026 margin* figure, a legitimate and different claim
from the AI/personalisation contribution figure this defect class concerns; Section 5's fix-log entry
confirming removal). No live mis-citation of the AI/personalisation EBITDA figure to `Topics/EBITDA.md`
survives anywhere in the plan.

**Spot-check beyond the 9 (2-3 load-bearing claims per section, all 14 sections):** headline GMV/revenue/
EBITDA figures (S1, S9), the 175/120/55 investment split (S1, S2, S3, S4, S6, S9, S11, S14), talabat pro
uplift figures (S4, S7), multi-vertical engagement stats (S3, S4, S6, S7), CARC and Rewards/PostPaid
figures (S7), risk register figures (S10), CSR/EV figures (S11), Implementation Plan milestones (S12),
KPI baselines (S13) — each traces to a real Facts/Sources note or an Approved Assumptions Register row.
No new unsupported or misrouted claim found.

**Conclusion: zero open citation failures.** All 9 recorded hard failures independently re-verified
present and correct in the current (post-merge) draft state. Stage 17 is closed — Stage 18/19 are
unblocked with respect to citation integrity.

---

## Original audit — 2026-07-25 (fixes applied, superseded by the re-verification above)

Per `vault/Architecture/Business_Plan_Generation_Pipeline.md`, Stage 17 re-checks every claim in the
assembled 14-section plan together, specifically to catch duplicated/relocated claims and stale
cross-section references that per-section audits (Pass 1/2/3) could miss. Run as 7 parallel,
independent `evidence-citation-agent` threads, each covering 2 sections, each doing (1) a full citation
re-trace from scratch and (2) an explicit cross-section reference check (does section X's claim about
section Y still match Y's current text?).

## Mid-run incident: Section 13's file was actually missing

The Sections 13-14 audit thread found `Section_13_Monitoring_and_Evaluation.md` absent from
`Business_Plan_Drafts_v2/` entirely — not the usual iCloud working-tree duplicate artifact, but a real
**committed deletion**: commit `d6e5c16` ("Session 10: Pass 3 independent re-verification...") removed
117 lines / the whole file, evidently swept in by a broad `git add` while the recurring iCloud sync
artifact had the file in a deleted state. This also caused Section 1's audit to hard-fail on its two
citations to that file (see H1 below). **Restored from commit `6e7224b`** (the last commit with the
file intact, pre-dating the accidental deletion) mid-session, once the Sections 9-10 and 11-12 pairs had
already returned clean and it was safe to modify the working tree without disrupting a running agent.
Section 13 itself was **not re-audited** this round — the Sections 13-14 agent could only compare
against the old Pass 2 report, not the live file, so a fresh Stage 17 pass on Section 13 is still needed.

## Findings by section

### Section 1 — Executive Summary: **FAIL**
- **H1 (now resolved by restoration):** cited `Section_13_Monitoring_and_Evaluation.md` twice for
  churn-baseline claims; the file didn't exist at audit time. Now restored — the citation should resolve
  again, but this section's dependence on that file makes it worth a quick re-check once Section 13 itself
  is re-audited.
- **H2 (open):** states "GMV of USD 9.5 billion in FY2025 *(Section_02_Business_Description.md §2.1)*" —
  but Section 2 §2.1 actually states a different figure/year: USD 7,428mn, FY2024. The $9.5bn FY2025
  figure is real and correctly cited elsewhere in Section 1 (to `Problem_Charter.md`) — this instance is
  simply mis-attributed.
- **M1 (open):** "6.0% in Q4 2025" comparator attributed to `Problem_Charter.md` and Section 10 §10.3,
  neither of which states it — correctly stated in Section 9 §9.3/9.4 and Section 3 §3.3.
- Informational only: Section 1 claims Sections 4/5/12 have "zero defects, independently re-checked" —
  true as of Pass 3, but those sections' own frontmatter says "treat as Done only once Stage 17... re-clears
  it," and this very audit found further defects in 4 (see below). Not a Section 1 citation defect, but the
  claim should be softened once Stage 17 findings are in.
- 17 cross-section reference checks performed; all others passed, including the highest-risk one: Section
  1's OPT-003 "near-term priority" framing correctly matches Section 12's current, post-Pass-3 text.

### Section 2 — Business Description: PASS (1 moderate finding)
- **M2:** §2.3 states FY2026 EBITDA guidance as a single point, "6.0%→4.6%" (a real, disclosed "guided
  mid-range" figure) while Sections 1/9/10 use the full disclosed range "4.4-4.8%." Not individually wrong,
  but part of a whole-plan pattern — see **Cross-cutting finding 1** below.

### Section 3 — Market Analysis: **FAIL**
- **H (open):** §3.3 Strengths (+ traceability table) cites the AI-personalisation EBITDA figure
  (>USD14mn FY2024 → >USD30mn FY2025) to `Topics/EBITDA.md`, which contains no such figure — it's in
  `Topics/AI.md`. This is the identical defect class Section 4 had before its own Pass 3 fix, but it was
  never caught in Section 3, whose own Pass 2 review claimed "no other defect found." See **Cross-cutting
  finding 2**.
- **Moderate (open):** §3.2's talabat pro 32%→49% GMV-share claim is cited to `Topics/Talabat Pro.md` and
  `Topics/Multi-Verticality.md`, neither of which states those figures — correct source is
  `Facts/Talabat_Pro.md`.
- 10 cross-section reference checks performed; 9 passed (Section 3→10 risk links, Section 3→2 problem
  labels, Section 3→4 "natural anchor," DEC-009 status, dual-register citations all clean).

### Section 4 — Value Proposition: **FAIL**
- **H (open):** §4.2's "talabat pro subscriber GMV share has grown from 32% (Q1 2025) to 49% (Q1 2026)"
  carries no citation at all and no traceability-table row. The fact itself is true (verified against
  `Facts/Talabat_Pro.md`, `Value_Driver_Tree_v2.md` N-08) — Pass 2/3 verified the fact externally but never
  checked the drafted sentence itself carried a citation.
- **H (open, cross-section conflict with Section 3):** §4.3 states the FY2026 guided EBITDA margin as a
  single point, "6.0%→4.6% of GMV," uncited. The primary source (TLB-020) discloses a **range**,
  "4.4-4.8% of GMV," which Section 3 §3.3 states correctly and which matches `Value_Driver_Tree_v2.md`
  N-34 and Section 9's own financial table. See **Cross-cutting finding 1**.
- All four of Section 4's previously-fixed Pass 2/Pass 3 defects independently re-confirmed still correct.
- 10 cross-section reference checks performed; 9 passed cleanly (DEC-008 scope compliance across
  Sections 9/12/13, OPT-001–005 descriptions cross-checked against the Register, no drift).

### Section 5 — AI Technology and Development: PASS (1 moderate finding)
- Pass 3's two fixes (DEC-009 characterization; EBITDA citation retargeted to `Topics/AI.md`) both
  independently reconfirmed correct.
- **Moderate (self-resolving):** §5.5's "all 14 Business Plan sections" (itself a Pass 3 fix) was stale
  again at audit time because Section 13 was missing (13 files existed, not 14) — this was a symptom of
  the file-deletion incident above, not a new defect in Section 5's own reasoning. Should read correctly
  again now that Section 13 is restored, but flags how fragile this line is to the recurring sync issue.
- 11 cross-section reference checks performed, 11 passed.

### Section 6 — Business Model and Revenue Streams: PASS (1 moderate finding)
- **M1 (open):** §6.6's self-check claims "every revenue stream in §6.1 is traced to a specific Stage
  9/10 node (N-26 through N-30)" — false against §6.1's own table: only Commission (N-26) and Advertising
  (N-29) actually cite a Stage 9/10 node; Delivery & Service, Subscription, and Vouchers cite none, because
  `Value_Driver_Tree_v2.md`'s Stage 10 has no dedicated node for those three streams. A self-check wording
  defect, not a sourcing defect — the underlying revenue figures are independently well-sourced.

### Section 7 — Marketing and Sales Strategy: PASS, 0 hard failures
- Two informational/bookkeeping notes, neither a live claim defect: the provenance note references
  `ASM-024` as "cited as-is" but it never actually appears in the body (the Rewards/PostPaid figures are
  sourced directly instead); `Assumptions_Register.md`'s `ASM-016` "Used in" list omits Section 7 despite
  Section 7 citing it twice (a register-maintenance gap, not a Section 7 defect).
- 15 cross-section reference checks performed, 14 passed (§7.6's CARC-vs-Section-6 fix, confirmed correctly
  flagged rather than force-reconciled; §7.5's DEC-009/OPT-003 characterization confirmed verbatim-correct
  against the Decision Log).

### Section 8 — Operations Plan: PASS with one open hard failure
- **H (open):** §8.1 and §8.6 claim the 235TB/day data-processing figure was "already established in
  Section 5.4" — false. Section 5 §5.4 explicitly says the opposite ("talabat's own infrastructure is not
  itemized in the corpus beyond the Delivery Hero licensing relationship"), and "235" appears nowhere in
  Section 5. The figure itself is still correctly and independently sourced to TLB-002 page 15 — this is a
  stale/false cross-section pointer, not an unsupported number, but exactly the class of defect Stage 17
  exists to catch.
- Moderate/informational: an ambiguous (not incorrect) joint citation in §8.4.
- 15 cross-section reference checks performed, 14 passed.

### Section 9 — Financial Plan: PASS, 0 defects
Every claim independently re-traced from scratch; all arithmetic recomputed directly. No hard or moderate
findings in Section 9 itself.

### Section 10 — Risk Analysis: PASS, 0 defects
All 20 cross-section reference checks (across both this pair and referenced by others) passed, including
the specific check this audit round was designed to catch: confirmed no section besides the already-fixed
Section 14 ever carried a stale claim about Section 9's status.

### Section 11 — CSR and Responsible AI: PASS, 0 defects
All EV/emissions/tips/SME-partnership figures independently re-located verbatim in raw primary sources;
all risk-ID restatements (ORG-01/02/03, TECH-01, MKT-02) match Section 10's current text exactly.

### Section 12 — Implementation Plan (Three Horizons): PASS, 0 hard failures
- Pass 3's OPT-003 wording fix (removing the uncited "beyond ~USD55mn" claim) independently reconfirmed
  correctly applied.
- **Moderate (documentation-sync only, open):** the in-body pipeline provenance note (not the YAML
  frontmatter, which is correct) still only mentions Pass 2's two defects and omits Pass 3's fix — a
  documentation gap, not a citation error; the section's actual prose is correct.
- 13 cross-section reference checks performed, 13 passed.

### Section 13 — Monitoring and Evaluation: audited in a follow-up pass, **FAIL** (now fixed)
File was missing from the repository at the first audit round (see incident note above); restored, then
given its own dedicated Stage 17 pass once the file was stable. Two further findings:
- **Hard (repository hygiene, not content):** the restore initially landed under a stray, iCloud-sync-
  mangled filename (`"Section_13_Monitoring_and_Evaluation 2.md"`), which broke every `[[wikilink]]`
  pointing to the canonical name (Sections 1, 2, 14, and Section 13's own reciprocal links). This same
  sync artifact recurred **three more times** while re-filing it correctly during this session — each
  time, the file was renamed to a new numbered duplicate within seconds of being written. Fixed by
  writing directly to the canonical path and verifying it held; flagged to the user as a live,
  recurring environmental issue (see session notes) rather than something reliably fixable by retrying.
- **Hard (cross-section propagation, open until this pass):** Section 13's own Pass 2 fix (narrowing an
  overbroad churn-scope claim to "Group or Egypt specifically") was never propagated to two other
  sections stating the same fact — `Section_01_Executive_Summary.md` (still said "Group or any country
  level") and `Section_14_Appendices.md`'s traceability table (still said "Group or country level"). Both
  now contradicted Section 13's own corrected text. Fixed 2026-07-25 in both sections.
- Section 13's own body text was independently confirmed citation-clean, with all 3 Pass 2 fixes
  (Review Cadence section, KPI baseline periods, churn-scope wording) genuinely present in the restored
  file — the restore pulled the post-fix version, not a stale one. Frontmatter status claim confirmed
  accurate.
- Cross-section reference checks: Section 1's churn citation (now resolves correctly post-fix), Section
  14's KPI-count/family rows (exact match against `KPI_Tree_v2.md`), Section 2's general monitoring
  reference, Section 13's own DEC-008/DEC-007/Section 12 citations — all confirmed accurate.

### Section 14 — Appendices: FAIL, both findings now fixed
- **H (fixed):** §14.2's traceability-table row for Section 4's AI/personalisation EBITDA figure
  ("USD14mn+→USD30mn+") still cited `Topics/EBITDA.md` — the exact defect Section 4's own Pass 3 review
  found and fixed *inside Section 4* on 2026-07-24 (retargeted to `Topics/AI.md`), but the fix never
  propagated into Section 14's summary table. This is precisely the cross-section-drift failure Stage 17
  exists to catch. See **Cross-cutting finding 2**.
- **H (fixed, elevated from moderate to hard by Section 13's own Stage 17 pass):** the Section 13 churn
  row said "no churn rate... anywhere in the corpus, Group or country level" — this directly contradicted
  Section 13's own already-corrected text ("Group or Egypt specifically"), making it a stale cross-section
  claim, not merely an imprecise one. Fixed 2026-07-25.
- 43 of ~60 traceability rows individually re-traced (the Pass-2/3-fixed set — Sections 4, 5, 7, 8, 9, 12 —
  fully verified row by row; Sections 2, 3, 6, 10, 11 spot-checked). No numeric conflicts found.

## Cross-cutting findings (visible only because sections were checked together)

**1. EBITDA-margin guidance presented two different ways across the plan.** Sections 2 and 4 state the
FY2026 guided Adjusted EBITDA margin as a single point, "6.0%→4.6% of GMV" (uncited in Section 4;
attributed generally in Section 2). Sections 1, 3, 9, 10, 11, and 14 all state the full disclosed range,
"4.4-4.8% of GMV." Both framings trace to real disclosure (4.6% is the source's own stated "guided
mid-range"), so this is not a fabricated-number problem — but a plan built to Financial Integrity Gate
standards should present guidance the same way everywhere. Section 4's instance is additionally uncited
(see its H finding above), making it the one that actually needs a citation, not just consistent framing.

**2. The same `Topics/EBITDA.md`-vs-`Topics/AI.md` mis-citation recurs independently in three places.**
Sections 4 and 5 already had this exact defect and fixed it in Pass 3 (2026-07-24). This audit found it
freshly alive, uncaught, in **Section 3** (never previously flagged), and **stale/unpropagated** in
**Section 14's traceability table** (which still points at Section 4's pre-fix citation). Four independent
occurrences of one root cause — worth fixing as a single coordinated pass across Sections 3, 4 (already
fixed), 5 (already fixed), and 14's table, rather than four separate fixes.

**3. Stale cross-section status claims are rare but real, and this audit's targeted check for them
(prompted by Session 10's Section-14-about-Section-9 finding) mostly came back clean.** Of ~90
cross-section reference checks performed across all 7 pairs, only 3 were live failures: Section 1's
GMV mis-attribution, Section 8's false "established in Section 5.4" pointer, and Section 14's stale
EBITDA-citation row. No section besides the already-fixed Section 14 carries a stale claim about another
section's Pass 2/3-fixed status.

## Fixes applied (2026-07-25)

All 8 open hard failures fixed directly in the section drafts the same day this audit ran, plus the
cross-cutting `Topics/EBITDA.md`→`Topics/AI.md` mis-citation propagated to every occurrence found (not
just the ones individually flagged):

- **Section 1:** GMV-figure citation retargeted from `Section_02...§2.1` to `Problem_Charter.md`; the
  "6.0% Q4 2025" comparator given its correct citation (`Section_09_Financial_Plan.md` §9.3-9.4;
  `Section_03_Market_Analysis.md` §3.3), split out from the 4.8%/6.3% figures it was wrongly bundled with;
  the churn-scope claim narrowed from "Group or any country level" to "Group or Egypt specifically" to
  match Section 13's own already-corrected wording.
- **Section 3:** AI/personalisation EBITDA figure retargeted `Topics/EBITDA.md`→`Topics/AI.md` (prose +
  traceability table); pro GMV-share figure retargeted to `Facts/Talabat_Pro.md`.
- **Section 4:** pro GMV-share claim given a citation (`Facts/Talabat_Pro.md`; `Value_Driver_Tree_v2.md`
  N-08) plus a new traceability row; FY2026 EBITDA margin corrected from an uncited single point
  ("6.0%→4.6%") to the disclosed, cited range ("4.4-4.8%", matching Section 3 and Section 9).
- **Section 8:** the false "already established in Section 5.4" claim removed from both the 235TB/day
  figure (which is not in Section 5 at all — restated in full with its own TLB-002 p.15 citation) and the
  OS-infrastructure sentence (retargeted to the section that actually does describe it, §5.1/§5.4).
- **Section 14:** all 3 occurrences of the `Topics/EBITDA.md` mis-citation fixed — the traceability-table
  EBITDA row and the §13.2 prose restatement retargeted to `Topics/AI.md`; a third, previously-unflagged
  spurious citation to `Topics/EBITDA.md` on the "no disclosed ROI/payback figure" row (which `Topics/
  EBITDA.md` does not discuss at all) removed, leaving the correct sole citation to
  `Investment_Relationship_Map.md`; the Section 13 churn-scope row corrected to match Section 13's own
  wording.
- **Section 13 (follow-up pass):** the file itself re-filed under its correct name after a recurring
  iCloud sync artifact repeatedly renamed it during this session (fixed by writing directly to the
  canonical path); no content fix needed in Section 13's own text (already correct).

**Not yet fixed (out of this round's explicit scope, left open for a future pass):** Section 6's §6.6
node-coverage overclaim; Section 12's provenance-note documentation-sync gap; Section 2/4's residual
EBITDA-margin single-point-vs-range framing difference (now only Section 2 retains a single-point framing,
since Section 4's instance was corrected as a hard failure above — Section 2's is independently disclosed
and not miscited, just a framing inconsistency).

## Summary

- **9 hard failures found** across two audit rounds — 7 in the initial 7-pair round (Sections 1, 3, 4 ×2,
  8, 14) plus 2 more surfaced by Section 13's dedicated follow-up pass (a wikilink-breaking file-naming
  issue, and a stale churn-scope claim in Sections 1/14 that contradicted Section 13's own corrected
  text). 1 (Section 1's initial missing-file citation) resolved by restoring the deleted Section 13 file;
  **8 fixed directly in content 2026-07-25** (see above).
- **9 moderate/informational findings** from the first round, none blocking on their own; 8 remain open.
- **Section 13 now fully audited** — its own text is citation-clean; the propagation gap into Sections 1
  and 14 is fixed.
- **~95 cross-section reference checks performed** across both rounds, only 5 live failures found (~5%
  failure rate) — the plan's cross-section referencing is largely sound; the hard failures were
  concentrated in citation targeting (wrong document/node, missing citation, unpropagated fixes), not in
  fabricated or contradicted facts.
- **A live repository-hygiene issue surfaced and recurred repeatedly this session**, independent of
  content quality: an iCloud sync conflict that renames `Section_13_Monitoring_and_Evaluation.md` to a
  numbered duplicate within seconds of being written, observed 4 times total across this and the prior
  session. Worth the user's attention outside this audit — see session notes.
- **Verdict: fixes applied, re-verification pending.** Per the citation-audit skill's 0%-tolerance rule,
  Stage 18/19 still cannot proceed until a fresh independent pass re-confirms all 8 fixes above actually
  hold, per this project's standing two/three-pass discipline.

## Links
- `vault/Validation/Citation_Audit_WholePlan_Stage17_Sections01-02.md`
- `vault/Validation/Citation_Audit_WholePlan_Stage17_Sections03-04.md`
- `vault/Validation/Citation_Audit_WholePlan_Stage17_Sections05-06.md`
- `vault/Validation/Citation_Audit_WholePlan_Stage17_Sections07-08.md`
- `vault/Validation/Citation_Audit_WholePlan_Stage17_Sections09-10.md`
- `vault/Validation/Citation_Audit_WholePlan_Stage17_Sections11-12.md`
- `vault/Validation/Citation_Audit_WholePlan_Stage17_Sections13-14.md`
- `vault/Architecture/Business_Plan_Generation_Pipeline.md`
